Every peptide in the GLP-1 family works by binding to specific receptors on cells throughout the body
From a procurement perspective, this means legitimate retatrutide cannot realistically be priced at parity with semaglutide
It works by slowing digestion and increasing feelings of fullness, which reduces overall calorie intake
At BMS, the focus is on looking beyond a single marker integrating nutrition, metabolism, inflammation balance, and overall recovery status to support the body more comprehensively
At the end of the study, compared with those who took sulfonylureas, participants who continuously used GLP-1s over the 3-year period had the most pronounced risk reduction
Listen to GLP-1 Medications and Kidney Disease on Spotify or Apple Podcasts